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Abstract
Background: There is only limited accurate data on the epidemiology of rhinosinusitis in primary care.
This study was conducted to assess the incidence of acute and chronic rhinosinusitis by analysing data from two
Dutch general practice registration projects. Several patient characteristics and diseases are related to the diagnosis
rhinosinusitis.
Methods: The Continuous Morbidity Registration (CMR) and the Transitionproject (TP) are used to analyse the data
on rhinosinusitis in primary practice. Both registries use codes to register diagnoses.
Results: In the CMR 3244 patients are registered with rhinosinusitis and in the TP 5424 CMR: The absolute
incidence of (acute) rhinosinusitis is 5191 (18.8 per 1000 patient years). Regarding an odds ratio of 5.58, having
nasal polyps is strongest related to rhinosinusitis compared to the other evaluated comorbidities. A separate code
for chronic rhinosinusitis exists, but is not in use.
TP: Acute and chronic rhinosinusitis are coded as one diagnosis. The incidence of rhinosinusitis is 5574 or 28.7 per
1000 patient years. Patients who visit their general practitioner with “symptoms/complaints of sinus”, allergic rhinitis
and “other diseases of the respiratory system” have the highest chances to be diagnosed with rhinosinusitis.
Medication is prescribed in 90.6 % of the cases.
Conclusions: Rhinosinusitis is a common diagnosis in primary practice. In the used registries no difference could
be made between acute and chronic rhinosinusitis, but they give insight in comorbidity and interventions taken by
the GP in case of rhinosinusitis.
Background
Rhinosinusitis is one of the commonest reasons for gen-
eral practice visits and can have a substantial influence
on a person’s quality of life [1–4]. Despite the high
prevalence and significant morbidity of rhinosinusitis,
there is only limited accurate data on the epidemiology
of this condition. This is mainly due to the lack of an
generally accepted definition for rhinosinusitis and the
different patient selection criteria in epidemiological
studies.
A taskforce endorsed by the European Academy of
Allergology and Clinical Immonology and the European
Rhinologic Society has come up with clear unambigious
definitons of rhinosinusitis which can be used for epi-
demiological and clinical research (The European Pos-
ition Paper of Rhinosinusitis and Nasal Polyps, EPOS)
[5, 6]. EPOS is the first combined guideline for primary
and secondary medical care [5–7]. The EPOS definition
of rhinosinusitis is defined as two or more symptoms
one of which should be either nasal obstruction or nasal
discharge. Other possible symptoms are facial pain/pres-
sure or impairment of smell. In acute rhinosinusitis
(ARS), this condition is present for less than 12 weeks,
in chronic rhinosinusitis (CRS) for more than 12 weeks.
Recurrent rhinosinusitis is defined as at least 4 episodes
of rhinosinusitis within one year with complete reso-
lution of symptoms between the episodes [5, 6].
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In Europe, CRS is an underestimated disease. Data on
the prevalence of rhinosinusitis in European populations
are rare. For this reason the European Union has funded
a large epidemiological survey in more than 20 coun-
tries, the Global Allergy and Asthma European Network
(GA2LEN) survey, which provides the first European
epidemiological data on the prevalence of rhinosinusitis.
According to this publication, the overall prevalence of
CRS by EPOS criteria was 10.9 % [8]. In Portugal a study
was done with cadaver specimens with a mean age of
death of 77 years. The prevalence of nasal polyps was
5.5 % [9].
General practitioners (GPs) play a vital role in the
Dutch health care system. They are the gate-keepers to
specialist care. Nearly all inhabitants are registered with
a general practitioner. As most of the health problems
presented to GPs are not seen by specialists, general
practices are important sources of information about
common diseases [10]. In a survey by the Netherlands
Central Bureau for Statistics 60 per 1000 Dutch inhabi-
tants in 1992 considered themselves to suffer/have suf-
fered from rhinosinusitis [11].
The estimated incidence of ARS in Dutch general
practices in 2003 was 16.4 per 1000 men and 33.3 per
1000 women. This means that at total of 131,800 men
and 273,000 women were diagnosed with ARS in 2003
[12]. In the “Second National Study”, a report on dis-
eases and interventions in general practice, an incidence
of 22.1 per 1000 patients was reported. (15.2 per 1000
men and 28.8 per 1000 women) [13]. In the UK figures
of 25 per 1000 patient years have been reported [11]. No
differentiation was made between ARS and CRS in these
last two reports.
In the current study, two Dutch general practice mor-
bidity registrations projects were used; the Nijmegen
Continuous Morbidity Registration (CMR) and the
Transitionproject (TP). The aim of our study was to as-
sess the incidence of ARS and CRS diagnosed by GPs by
analysing data from these two Dutch general practice
registration projects. We also looked at patient charac-
teristics, comorbidity, reasons for consulting the GP and
interventions taken by the GP.
Methods
This retrospective case-control study did not need ap-
proval of an ethical board since the anonymous partici-
pants in the already existing database were not submitted
to investigations or actions as part of this study.
General practice morbidity registrations
We used the databases of the following two general
practice morbidity registrations to estimate the incidence
of ARS and CRS. Permission was granted to access both
databases.
Nijmegen Continuous Morbidity Registration
The CMR involves four general practices in the region
of Nijmegen in the Netherlands. The goal of the CMR is
to generate epidemiological numbers concerning dis-
eases in the general practice population for the purpose
of education and scientific research. Since 1971 all com-
mon diseases and all referrals to specialists are entered
in this registration, as are all hospital admissions [14].
Background information like date of birth, gender, socio-
economic status, date of practice entry, date and reason
of leaving the practice is also registered. Socioeconomic
status is divided in three social classes, which are based
on the occupation of the wage earner (based on a classi-
fication of the Institute for Applied Sociology).
For the current study we used CMR data from 1985
until 2006 comprising an average population of approxi-
mately 12,000 patients and 275,602 patient years. All pa-
tients who had been diagnosed with rhinosinusitis were
included in this study. In the CMR a list of codes based
on the E-list (compatible with the ICHPPC-2-defined
criteria (ICHPPC: International Classification of Health
Problems in Primary Care)) is used (Fig. 1). In the CMR,
separate codes for ARS and CRS exist. However, the
code for CRS is not used consistently (as a result of an
agreement between the participating GPs). To indicate
whether a visit was for a new episode or for an already
existing episode, the GPs in the CMR practices use a
special code linked to the diagnosis. When the code for
an already existing episode of rhinosinusitis was used,
that (same) episode was not included again for calcula-
tion of the incidence of rhinosinusitis [14, 15].
Transition project
The TP’s goal is to develop and apply episode-oriented
epidemiology in general practice by coding all diagnoses
by the International Classification of primary Care (ICPC).
Participating GPs register all contacts between patient and
GP and all actions that result from the contact. The data
from 1985 until 2002 are based on a population from
three practices in the city of Amstelveen and two practices
in the province of Friesland with approximately 18,000 pa-
tients and 201,137 patient years of observation. Variables
that are documented in the TP are patient characteristics,
reasons for encounter, interventions initiated by the GP
and referrals [14]. Only the kind of intervention was
coded, for example prescription of medication, but not
exactly which medicament was prescribed. Figure 1 shows
the criteria for inclusion in the rubric rhinosinusitis [16].
The code for reason for encounter could represent a
complaint or the diagnosis itself. In the latter case, the
patient had the suspicion of having that particular dis-
ease and reported this to the GP.
In the TP no difference is made between ARS and
CRS. However, the length of the episodes of care is
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registered in the TP and we tried to use this information
to discriminate between ARS and CRS.
Comorbidity
The commonest comorbidities or predisposing conditions
for rhinosinusitis mentioned in literature [1, 5, 6, 17] are:
viral infections (upper respiratory tract infections), allergic
rhinitis, anatomical variations of the nose, immunocom-
promised state, nasal polyps, asthma/COPD (chronic ob-
structive pulmonary disease) and dental infections. Nasal
polyps may be part of the diagnosis (chronic) rhinosinusitis,
but a separate code in which nasal polyps are mentioned
exists in both morbidity registrations. These characteristics
were included in the study and related to the diagnosis
rhinosinusitis.
Statistical analysis
We analysed the data from the CMR and TP by calcula-
tion of odds ratios (odds of comorbidity in rhinosinusitis
population/odds of comorbidity in population without
rhinosinusitis). Statistically an odds ratio above 1.0 and a
95 % confidence interval not including 0 is a significant
association, but maybe not clinically relevant, therefore
we considered an odds ratio of more than 3.0 in com-
bination with the lower limit of the 95 % confidence
interval above 2 · 0 to be a relevant association.
Results
Incidence of ARS and CRS in the CMR
Based on the above mentioned criteria, a total of 3244
patients were found to be registered with one ore more
episodes of ARS in the CMR in the period 1985 to
2006.The incidence of ARS in the CMR was 5191, corre-
sponding with 18.8 per 1000 patientyears. ARS incidence
varied slightly over the years, with an apparent trend to
lower incidence in the period 1989 to 2004. The code
for incident cases of CRS was only used in 33 cases (0.1
per 1000 patientyears). The prevalence of ARS and CRS
was 5197 (18.9 per 1000 patientyears) and 65 (0.2 per
1000 patientyears) respectively.
Fig. 1 Inclusion in rubric rhinosinusitis
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The population with rhinosinusitis in the CMR was
mainly from the lowest social class (40 · 1 %); 14 · 4 %
was from the highest social class.
The incidence of ARS was unequally distributed over
the age groups and sexes. The incidence in men was 14 ·
4, in women 23 · 1 per 1000 patient years (Fig. 2). The
incidence was highest in the 25–44 years age group, with
39 · 4 per 1000 patient years for women and 23 · 4 per
1000 patient years for men. There were 27 children
below the age of 4 who had been diagnosed with ARS.
Incidence of ARS and CRS in the TP
Reliable determination of the length of episodes was not
possible in the TP data, despite the code for the end of an
episode. Because an episode can end in between two visits
to the GP, the exact end of an episode remains unknown.
Therefore no discrimination between ARS and CRS could
be made. In the TP 5424 patients had been diagnosed with
one or more episodes of rhinosinusitis in the period 1985
to 2002. The total incidence of rhinosinusitis in the TP was
5574, or 28 · 7 per 1000 patient years. The distribution of
rhinosinusitis over the age groups and sexes was compar-
able to the distribution in the CMR (Fig. 2). The incidence
in men was 21 · 3 per 1000 patient years, in women 35 · 6
per 1000 patient years. Again, the incidence was highest in
the 25–44 years age group. The incidence of rhinosinusitis
in women was 53 · 3 per 1000 patient years and in men
29 · 3 per 1000 patient years. In the TP 100 children aged
0–4 years had been diagnosed with rhinosinusitis.
Number of episodes with rhinosinusitis
GPs of the CMR reported a total of 3244 patients having
5191 episodes of acute rhinosinusitis between 1985 and
2006. Most of these patients (69 %) only had one episode
during the period of registration, the rest had one or
more relapses. Most of them (18 %) had one docu-
mented relapse, one patient even had up to 22 relapses.
Only four patients met the criteria for recurrent rhinosi-
nusitis mentioned before.
In the TP database 5424 patients experienced 5774 in-
cident cases of rhinosinusitis.
Comorbidity and rhinosinusitis
To assess whether comorbidity was related to the inci-
dence of ARS in the CMR database, a few diagnoses were
related to the diagnosis “ARS”. Table 1 compares the inci-
dence of comorbidity in the rhinosinusitis group with the
incidence of morbidity in the population without rhinosi-
nusitis. The rhinosinusitis population represented 50,888
patient years. With an odds ratio of 5.58 and the lower
limit of the 95 % confidence interval being 4.46, “nasal
polyps” was the only comorbid condition that was signifi-
cantly associated with rhinosinusitis. With an odds ratio
of 2.88 (95%CI 2.70 to 3.07), allergic rhinitis showed a ten-
dency towards a significant association. Analysis of co-
morbidity from the TP also showed an association
between allergic rhinitis and rhinosinusitis and between
“other diseases of the respiratory system” and rhinosinusi-
tis (Table 2). The other selected diseases did not meet the
cut-off to confirm a significant association.
Reason for encounter in rhinosinusitis
Analysis of the TP database showed that the commonest
reason for encounter before the GP recorded rhinosinusi-
tis as his/her diagnosis was “Symptoms/complaints sinus,
including pain”. Other frequent reasons for encounter
were upper respiratory tract infections and headache.
Children aged 0 to 4 years consulted with a cough or fever
relatively often. Adolescents’ (age between 15 and 24 years)
top-3 reasons for encounter were cough, headache and
symptoms/complaints of the sinus. Patients older than 65
usually came with symptoms/complaints of the sinus, but
also relatively often with a cough (Table 3).
Fig. 2 Incidence of acute rhinosinusitis in men and women of different age groups. CMR and TP
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GPs’ interventions for rhinosinusitis
Table 5 shows the diagnostic assessment and interven-
tions of the GP for patients with rhinosinusitis from the
TP database. GPs medically examined most patients and
almost 91 % received a prescription for medication to
treat the rhinosinusitis. Unfortunately, no details were
recorded about the precise examinations the GPs per-
formed and the medication that was prescribed. Of all
patients diagnosed with rhinosinusitis by the GPs, 7 · 6 %
was sent for diagnostic radiology.
Young children (aged 0–4 years) received less prescrip-
tions for medication than patients in other age groups,
but were referred more often than patients from other age
groups (Table 4). Of the total population 2 · 7 % was re-
ferred to a medical specialist. A higher percentage of chil-
dren, aged between 0 and 4 was referred.
Discussion
Main Findings
Although clear unambigious definitons of rhinosinusitis
have been published, the diagnosis of rhinosinusitis in
general practice remains complicated. Firstly the dis-
crimination between rhinosinusitis and other upper air-
way diseases is difficult [5, 6, 18]. The symptomatology
of rhinitis and rhinosinusitis overlap. When the patient
has nasal blockage, purulent discharge and/or facial pain,
it may be impossible to make an adequate diagnosis
without nasal endoscopy or CT scan, none of which are
usually available in the GP practice [19, 20]. It was found
that questionnaire-based and clinical based CRS show
moderate correlation [21]. On the other hand, symptom-
based CRS (based on EPOS criteria) has been shown to
be significantly associated with positive endoscopy in
nonallergic subjects [22].
In the two registries the GPs do not seem to differenti-
ate between ARS and CRS, which may just be a matter
of limitations of the studied registries. In a previous
study from our group 69 % of Dutch GPs reported to
discriminate between ARS and CRS. However, their defi-
nitions of ARS and CRS varied [23].
Almost 91 % of the patients with rhinosinusitis received
a prescription for medication. Antibiotics are still pre-
scribed quite often for this indication [23], even though
we know that antibiotics do not influence the clinical
course of sinusitis nor the rate of relapses during 1-year
follow-up [24, 25]. Initial management can be limited to
symptomatic treatment only [26, 27]. In 7 · 6 % of the rhi-
nosinusitis patients in our study diagnostic radiography
was performed. In ARS, X-rays have no prognostic
value nor therapeutical consequences [26]. In patients
with clinical diagnosis of ARS it has been shown that
less than half actually have significant abnormalities at
X-ray examination [28].
From the data of the TP, it seems that young children
are referred more easily than patients in other age
groups. A likely explanation for this observation is that
GPs are more cautious when they treat very young chil-
dren. However, the analysis of a subgroup of only 100
children is not as reliable as the analysis on the other
(larger) age groups.
Strengths and limitations of this study
It is possible that the incidence of rhinosinusitis in this
study is overestimated, because the diagnosis is only based
on symptoms and physical examination by the GP. For
the diagnosis we depend on the GP’s assessment, we are
not sure that inclusion criteria are strictly followed. Based
on sinus puncture/aspiration (which is considered the
most accurate diagnostic test), 49–83 % of a population of
symptomatic patients was proven to have ARS [29]. Fur-
thermore, we do not know whether patients who pre-
sented with a “second” episode had complete resolution of
the symptoms in between their contacts with the GP.
Therefore differentiation between “recurrent” ARS and
CRS is not possibible. On the other hand, incidence could
be underestimated, because many patients with com-
plaints, and possibly rhinosinusitis, do not visit their GP.
Questionnaire-based studies on rhinosinusitis exist
showing a prevalence of, for example, CRS of 10.9 % in
Europe and even 14.3 % in Amsterdam, the Netherlands
[8]. This is much higher than the numbers found in
current study for rhinosinusitis overall (ARS and CRS
together), but it is known that questionnaire-based and
clinical-based CRS show only moderate correlation [21].
Unfortunately, we could not discriminate between ARS
and CRS in either of the two registries used. In the CMR,
Table 1 Odds ratio of morbidity for patients with rhinosinusitis
relative to controls without rhinosinusitis, CMR
Comorbidity Odds ratio 95 % CI
Viral infection (without fever) 1.57 1.53–1.62
Allergic rhinitis 2.88 2.70–3.07
Dental infections 1.40 1.29–1.52
Asthma 1.46 1.38–1.54
Nasal polyps 5.58 4.46–6.97
Table 2 Odds ratio morbidity (odds morbidity in rhinosinusitis/
odds morbidity non-rhinosinusitis), TP
Comorbidity Odds ratio 95 % CI
Allergic rhinitis 4.06 3.62–4.55




Upper resp. tract infections 2.16 1.99–2.34
Emphysema/COPD 1.11 0.84–1.46
Disease of teeth/gums 1.07 0.72–1.58
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there is a separate code for chronic rhinosinusitis but the
GPs from the CMR have decided not to use this code. In
the TP it depends on the assessment of the GP whether a
visit for an episode of rhinosinusitis following an earlier
episode is considered a new episode or part of the same
episode. Furthermore, it is not possible to determine the
end of an episode, since the patient can recover in a
period between contacts with the GP. Therefore it was im-
possible to determine the duration of rhinosinusitis epi-
sodes properly.
The incidence of rhinosinusitis in the TP is higher than
the incidence in the CMR. Due to missing values in the
TP, further statistical analysis of this difference was not
possible. A possible explanation for the difference could
be the fact that in the TP, the diagnosis is coded as acute/
chronic rhinosinusitis. All diagnoses related to rhinosinu-
sitis fit into this group. In the CMR, there are separate
diagnose codes for ARS and CRS. The code for CRS is not
used, but certain symptoms/complaints concerning the
sinus do not fit into the ARS group and are probably
coded otherwise. Furthermore, the criteria for inclusion in
the rubric rhinosinusitis were less strict in the TP.
Not all predisposing factors could be analysed, because of
their low incidence in the databases. Immunocompromised
state, for example, was too uncommon to analyse. Other
conditions had no separate code in the registries. Therefore
these conditions could not be compared to the data of the
TP. In both registries anatomical variations of the nose
were not specifically coded and therefore could not be ana-
lysed. Another limitation of this study is that our results
can not be easily compared to data of other studies, because
it appears that this kind of analysis of GP registries has not
been done before.
Ideally registries with clear inclusion criteria for rhino-
sinusitis, using the unambiguous definitons of rhinosinu-
sitis as defined in EPOS, should be used in a study like
this. Information on interventions should be more pre-
cise, giving more insight in the medicaments prescribed
and the diagnostic radiology that is applied for.
Interpretation of findings in relation to previously
published work
Okkes et al. compared data from a general population
health survey of the Dutch Central Bureau for Statistics
(CBS) about episodes of chronic diseases experienced by
the respondents with data from general practice registra-
tion projects. The health survey resulted in higher frequen-
cies than the GP registration for respiratory disorders,
Table 3 Reason for encounter in rhinosinusitis cases (n = 5774). Absolute numbers and percentage per age group. Top 10. TP
Age group
Label reason for encounter Total N (%) 0–4 N (%) 5–14 N (%) 15–24 N (%) 25–44 N (%) 45–64 N (%) 65–74 N (%) 75+ N (%)
1 Symptoms or complaints
of sinus (including pain)a
2001 (24.5) 7 (4.6) 60 (11.8) 196 (21.8) 1131 (29.7) 417 (22.7) 133 (20.9) 57 (18.3)
2 Upper respiratory infection
(common cold)
1000 (12.3) 16 (10.5) 60 (11.8) 126 (14.0) 464 (12.2) 243 (13.3) 54 (8.5) 37 (11.9)
3 Headacheb 994 (12.2) 6 (3.9) 84 (16.5) 148 (16.4) 457 (12.0) 192 (10.5) 66 (10.4) 41 (13.2)
4 Cough 947 (11.6) 38 (24.8) 100 (19.6) 90 (10.0) 333 (8.7) 211 (11.5) 121 (19.1) 54 (17.4)
5 Sinusitis, acute or chronicc 784 (9.6) 3 (2.0) 9 (1.8) 69 (7.7) 429 (11.3) 218 (11.9) 43 (6.8) 13 (4.2)
6 Fever 386 (4.7) 35 (22.9) 60 (11.8) 31 (3.4) 141 (3.7) 70 (3.8) 30 (4.7) 19 (6.1)
7 Symptoms or complaints of throat 237 (2.9) 2 (1.3) 13 (2.5) 43 (4.8) 88 (2.3) 64 (3.5) 20 (3.1) 7 (2.3)
8 Medication/prescription/injection 218 (2.7) 1 (0.7) 4 (0.8) 10 (1.1) 115 (3.0) 71 (3.9) 13 (2.0) 4 (1.3)
9 Sneezing/nasal congestion 211 (2.6) 4 (2.6) 17 (3.3) 36 (4.0) 81 (2.1) 37 (2.0) 26 (4.1) 10 (3.2)
10 General weakness/tiredness 181 (2.2) 8 (5.2) 20 (3.9) 21 (2.3) 73 (1.9) 29 (1.6) 17 (2.7) 13 (4.2)
aLabel “Symptoms or complaints of sinus”: patients present themselves with complaints
bexcluded were: N02 = Tension headache. N89 =Migraine. R09 = Sympt/complt sinus
cLabel “Sinusitis”: patients present themselves with the suspicion of having rhinosinusitis
Table 4 Percentage of rhinosinusitis cases (n = 5774) with interventions. TP
Age group
Label Total 0–4 5–14 15–24 25–44 45–64 65–74 75+
1 Medical examination or health evaluation 91.3 95.0 94.0 94.2 90.5 89.5 93.2 94.0
2 Medication prescription or injection 90.6 84.0 86.3 90.4 90.0 92.4 92.7 92.1
3 Advice or health education 22.3 18.0 26.6 23.5 24.4 17.9 18.1 24.1
4 Diagnostic radiology/imaging 7.6 9.0 9.9 7.1 7.3 8.1 6.8 6.9
5 Referral to medical specialist or hospital 2.7 9.0 2.1 2.0 2.3 3.1 3.3 4.2
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including rhinosinusitis (mostly in the age group of 25–44
years). In the CBS health survey 60 per 1000 inhabitants in
the Netherlands in 1992 self-reported a diagnosis of rhino-
sinusitis. These numbers were compared to the numbers
of three GP registries showing prevalences between 21 and
31 per 1000 patient years [11]. The differences between
men and women and age groups found in this study con-
firm data found in the Second National Study [13]. The
reason for the difference between men and women is still
unclear [30]. Most of the predisposing factors for rhinosi-
nusitis found in the literature, like nasal polyps, allergic
rhinitis and other diseases of the respiratory system, were
also predisposing factors in the current study [1, 5, 6, 17].
In the Dutch guideline for rhinosinusitis, GPs are ad-
vised to do a medical examination only in case of long-
lasting or severe complaints [30]. It is remarkable that 91 ·
3 % of the patients with an incident episode was examined
by the GP. It is also remarkable to see that 90 · 6 % of
these patients got a prescription for medication. Unfortu-
nately, we do not know which medication was prescribed.
Decongestants, antibiotics, analgesics, nasal steroids and
antihistamines are some of the commonly prescribed
treatments, but cannot be confirmed by this study [1, 5, 6,
23, 30]. These numbers are comparable to the result of an
observational study on acute maxillary sinusitis in France
and Asia [31, 32].
Implications for future research, policy and practice
The guideline on rhinosinusitis of the Dutch College of
General Practitioners did not discriminate between ARS
and CRS until Octobre 2014 [30]. A considerable amount
of data suggests that ARS and CRS are independent dis-
eases with different treatments [5, 6, 33]. Therefore, a
guideline discriminating between ARS and CRS would be
better. Since Octobre 2014 a new guideline for GPs has
been published in which the word “acute” is added to the
title “rhinosinusitis”. Still there is no separate guideline for
CRS [34].
To evaluate the management of rhinosinusitis of the
GP in more depth, we conducted a study with additional
information on e.g. medication policy [23].
Conclusions
Rhinosinusitis is a common diagnosis in general practice.
Based on two morbidity registrations in general practice,
the diagnosis can be related to several other diagnoses as
allergic rhinitis and nasal polyps. Medication is prescribed
in 91 % of the cases and almost 8 % is sent for diagnostic
radiology.
Based on the two general practice registries and the
Dutch GP guidelines, GPs do not seem to make a differ-
ence between ARS and CRS. The incidence of these two
diseases could not be assessed separately. Because the
different pathophysiology, diagnosis and treatment of
these entities, this would deprive patients with rhinosi-
nusitis of optimal care.
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